1. Home
  2. ADTX vs SINT Comparison

ADTX vs SINT Comparison

Compare ADTX & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • SINT
  • Stock Information
  • Founded
  • ADTX 2017
  • SINT 1996
  • Country
  • ADTX United States
  • SINT United States
  • Employees
  • ADTX N/A
  • SINT N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • SINT Medical/Dental Instruments
  • Sector
  • ADTX Health Care
  • SINT Health Care
  • Exchange
  • ADTX Nasdaq
  • SINT Nasdaq
  • Market Cap
  • ADTX 5.3M
  • SINT 4.6M
  • IPO Year
  • ADTX 2020
  • SINT 2014
  • Fundamental
  • Price
  • ADTX $0.13
  • SINT $3.18
  • Analyst Decision
  • ADTX
  • SINT Hold
  • Analyst Count
  • ADTX 0
  • SINT 1
  • Target Price
  • ADTX N/A
  • SINT N/A
  • AVG Volume (30 Days)
  • ADTX 39.3M
  • SINT 156.3K
  • Earning Date
  • ADTX 11-18-2024
  • SINT 11-12-2024
  • Dividend Yield
  • ADTX N/A
  • SINT N/A
  • EPS Growth
  • ADTX N/A
  • SINT N/A
  • EPS
  • ADTX N/A
  • SINT N/A
  • Revenue
  • ADTX $212,107.00
  • SINT $3,247,000.00
  • Revenue This Year
  • ADTX $95.61
  • SINT $15.42
  • Revenue Next Year
  • ADTX $1,584.79
  • SINT $14.58
  • P/E Ratio
  • ADTX N/A
  • SINT N/A
  • Revenue Growth
  • ADTX N/A
  • SINT 30.40
  • 52 Week Low
  • ADTX $0.12
  • SINT $2.01
  • 52 Week High
  • ADTX $218.00
  • SINT $65.00
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 18.05
  • SINT 43.08
  • Support Level
  • ADTX $0.12
  • SINT $3.10
  • Resistance Level
  • ADTX $0.21
  • SINT $3.94
  • Average True Range (ATR)
  • ADTX 0.03
  • SINT 0.28
  • MACD
  • ADTX 0.03
  • SINT -0.06
  • Stochastic Oscillator
  • ADTX 9.91
  • SINT 8.00

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: